{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:04:38Z","timestamp":1792652678495,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012111","name":"Foundation for Liver Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jhepr.2020.100151","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T13:35:48Z","timestamp":1596116148000},"page":"100151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis"],"prefix":"10.1016","volume":"2","author":[{"given":"Antonio","family":"Riva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth H.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Azarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane","family":"Zamalloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.W.","family":"McPhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Royce P.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Chokshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6616-3628","authenticated-orcid":false,"given":"Vishal C.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey A.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2020.100151_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2020.100151_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrgastro.2013.35","article-title":"The gastrointestinal mucus system in health and disease","volume":"10","author":"Johansson","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2020.100151_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/gutjnl-2018-316906","article-title":"Tight junction proteins in gastrointestinal and liver disease","volume":"68","author":"Zeisel","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2020.100151_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nri.2015.17","article-title":"Mucosal immunity to pathogenic intestinal bacteria","volume":"16","author":"Perez-Lopez","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2020.100151_bib5","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.aad0135","article-title":"A\u00a0gut-vascular barrier controls the systemic dissemination of bacteria","volume":"350","author":"Spadoni","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jhepr.2020.100151_bib6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100151_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cgh.2018.08.008","article-title":"Altered microbiome in patients with cirrhosis and complications","volume":"17","author":"Acharya","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2020.100151_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2217\/imt.15.27","article-title":"Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure","volume":"7","author":"Bernsmeier","year":"2015","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jhepr.2020.100151_bib9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/j.gastro.2014.11.041","article-title":"Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis","volume":"148","author":"Markwick","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2020.100151_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100151_bib11","first-page":"486","article-title":"Bacterial translocation markers in liver cirrhosis","volume":"30","author":"Alexopoulou","year":"2017","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100151_bib12","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1038\/nrdp.2016.41","article-title":"Acute-on-chronic liver failure in cirrhosis","volume":"2","author":"Arroyo","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhepr.2020.100151_bib13","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2020.100151_bib14","doi-asserted-by":"crossref","first-page":"8210","DOI":"10.1038\/s41598-018-26509-y","article-title":"Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy","volume":"8","author":"Iebba","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2020.100151_bib15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cell.2015.08.058","article-title":"Th17 cell induction by adhesion of microbes to intestinal epithelial cells","volume":"163","author":"Atarashi","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2020.100151_bib16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ibd.21852","article-title":"Enterotoxin-producing staphylococci cause intestinal inflammation by a combination of direct epithelial cytopathy and superantigen-mediated T-cell activation","volume":"18","author":"Edwards","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhepr.2020.100151_bib17","doi-asserted-by":"crossref","first-page":"e27030","DOI":"10.1371\/journal.pone.0027030","article-title":"Bacterial-epithelial contact is a key determinant of host innate immune responses to enteropathogenic and enteroaggregative Escherichia coli","volume":"6","author":"Edwards","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2020.100151_bib18","doi-asserted-by":"crossref","first-page":"e15398","DOI":"10.1371\/journal.pone.0015398","article-title":"Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection","volume":"5","author":"Edwards","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2020.100151_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/mp.50.3.113","article-title":"Functional and clinical aspects of the myelomonocyte protein calprotectin","volume":"50","author":"Johne","year":"1997","journal-title":"Mol Pathol"},{"key":"10.1016\/j.jhepr.2020.100151_bib20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.2005.069476","article-title":"Laboratory markers in IBD: useful, magic, or unnecessary toys?","volume":"55","author":"Vermeire","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2020.100151_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00054725-200606000-00013","article-title":"Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease","volume":"12","author":"Konikoff","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhepr.2020.100151_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/17474124.2014.869476","article-title":"The use of fecal calprotectin as a biomarker in gastrointestinal disease","volume":"8","author":"Burri","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2020.100151_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000354689","article-title":"Diagnostics and prognostics of inflammatory bowel disease with fecal neutrophil-derived biomarkers calprotectin and lactoferrin","volume":"31","author":"Sipponen","year":"2013","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhepr.2020.100151_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/CEG.S97701","article-title":"Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome","volume":"9","author":"von Arnim","year":"2016","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100151_bib25","first-page":"302","article-title":"The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis","volume":"77","author":"Alempijevic","year":"2014","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.jhepr.2020.100151_bib26","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.4049\/jimmunol.1602000","article-title":"Innate control of adaptive immunity: beyond the three-signal paradigm","volume":"198","author":"Jain","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2020.100151_bib27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.immuni.2011.10.013","article-title":"Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment","volume":"35","author":"Hu","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2020.100151_bib28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev-pathol-011110-130318","article-title":"The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin","volume":"8","author":"Weaver","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jhepr.2020.100151_bib29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1586\/eci.10.34","article-title":"Mucosal T cells in gut homeostasis and inflammation","volume":"6","author":"van Wijk","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jhepr.2020.100151_bib30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature07240","article-title":"ATP drives lamina propria T(H)17 cell differentiation","volume":"455","author":"Atarashi","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2020.100151_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.chom.2008.09.009","article-title":"Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine","volume":"4","author":"Ivanov","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhepr.2020.100151_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cyto.2016.12.017","article-title":"From stable disease to acute-on-chronic liver failure: circulating cytokines are related to prognosis in different stages of cirrhosis","volume":"91","author":"Fischer","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.jhepr.2020.100151_bib33","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Claria","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100151_bib34","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100151_bib35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhepr.2020.100151_bib36","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients waiting for liver transplantation reply","volume":"359","author":"Kim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2020.100151_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MOG.0b013e32833867d8","article-title":"Organ allocation for chronic liver disease: model for end-stage liver disease and beyond","volume":"26","author":"Asrani","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100151_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","article-title":"The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure","volume":"62","author":"Jalan","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100151_bib39","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/jir.2019.0011","article-title":"Mechanisms by which the gut microbiota influences cytokine production and modulates host inflammatory responses","volume":"39","author":"Mendes","year":"2019","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.jhepr.2020.100151_bib40","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3389\/fimmu.2019.00607","article-title":"Interactions between the gut microbiota and the host innate immune response against pathogens","volume":"10","author":"Cheng","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2020.100151_bib41","doi-asserted-by":"crossref","first-page":"e1007614","DOI":"10.1371\/journal.ppat.1007614","article-title":"Interleukin 21 collaborates with interferon-gamma for the optimal expression of interferon-stimulated genes and enhances protection against enteric microbial infection","volume":"15","author":"Solaymani-Mohammadi","year":"2019","journal-title":"Plos Pathog"},{"key":"10.1016\/j.jhepr.2020.100151_bib42","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2020.100151_bib43","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3389\/fimmu.2018.01270","article-title":"Cytokine tuning of intestinal epithelial function","volume":"9","author":"Andrews","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2020.100151_bib44","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2174\/187153007782794308","article-title":"Interleukin-21 (IL-21) controls inflammatory pathways in the gut","volume":"7","author":"Fina","year":"2007","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.jhepr.2020.100151_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41575-018-0084-8","article-title":"IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting","volume":"16","author":"Moschen","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2020.100151_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4161\/viru.25436","article-title":"Host innate immune responses to sepsis","volume":"5","author":"Wiersinga","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.jhepr.2020.100151_bib47","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2020.100151_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.plefa.2014.10.001","article-title":"Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine","volume":"93","author":"Gajda","year":"2015","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jhepr.2020.100151_bib49","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/gutjnl-2017-314458","article-title":"Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease","volume":"67","author":"Riva","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2020.100151_bib50","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000338086","article-title":"Beyond lactate: is there a role for serum lactate measurement in diagnosing acute mesenteric ischemia?","volume":"29","author":"Demir","year":"2012","journal-title":"Dig Surg"},{"key":"10.1016\/j.jhepr.2020.100151_bib51","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.clinbiochem.2008.06.011","article-title":"Analytical investigation: assay of D-lactate in diabetic plasma and urine","volume":"41","author":"Talasniemi","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jhepr.2020.100151_bib52","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jmv.20630","article-title":"Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to noroviruses","volume":"78","author":"Ko","year":"2006","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jhepr.2020.100151_bib53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0140-6736(92)90999-J","article-title":"Tumour necrosis factor alpha in stool as a marker of intestinal inflammation","volume":"339","author":"Braegger","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2020.100151_bib54","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3109\/00365521.2011.615857","article-title":"Limited value of fecal calprotectin in patients with liver cirrhosis","volume":"46","author":"Burri","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100151_bib55","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1478-3231.2011.02577.x","article-title":"Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis","volume":"31","author":"Gundling","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2020.100151_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/jir.2019.0011","article-title":"Mechanisms by which the gut microbiota influences cytokine production and modulates host inflammatory responses","volume":"39","author":"Mendes","year":"2019","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.jhepr.2020.100151_bib57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.MIB.0000437616.37000.41","article-title":"Targeting interleukins for the treatment of inflammatory bowel disease\u2014what lies beyond anti-TNF therapy?","volume":"20","author":"McLean","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhepr.2020.100151_bib58","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.immuni.2015.06.024","article-title":"Growth factor FGF2 cooperates with interleukin-17 to repair intestinal epithelial damage","volume":"43","author":"Song","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2020.100151_bib59","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.4049\/jimmunol.1601066","article-title":"Epithelial TNF receptor signaling promotes mucosal repair in inflammatory bowel disease","volume":"199","author":"Bradford","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2020.100151_bib60","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.4049\/jimmunol.1201876","article-title":"Mechanism of IL-1\u03b2 modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation","volume":"190","author":"Al-Sadi","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2020.100151_bib61","doi-asserted-by":"crossref","first-page":"E5076","DOI":"10.1073\/pnas.1718902115","article-title":"A\u00a0cytokine network involving IL-36gamma, IL-23, and IL-22 promotes antimicrobial defense and recovery from intestinal barrier damage","volume":"115","author":"Ngo","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2020.100151_bib62","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/eji.201646723","article-title":"IL-17 and IL-22 in immunity: driving protection and pathology","volume":"47","author":"Eyerich","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhepr.2020.100151_bib63","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.it.2010.06.004","article-title":"IL-17 and IL-22: siblings, not twins","volume":"31","author":"Eyerich","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jhepr.2020.100151_bib64","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.immuni.2010.03.001","article-title":"Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways","volume":"32","author":"Nava","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2020.100151_bib65","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cyto.2012.06.014","article-title":"New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation","volume":"59","author":"Bamias","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.jhepr.2020.100151_bib66","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhepr.2020.100151_bib67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2012.08.019","article-title":"Targeting gut flora to prevent progression of hepatocellular carcinoma","volume":"58","author":"Darnaud","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100151_bib68","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jhep.2020.03.027","article-title":"The innate immune cells in cirrhosis","volume":"73","author":"Bernsmeier","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100151_bib69","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/hep4.1465","article-title":"Biologic and checkpoint inhibitor-induced liver injury: a systematic literature review","volume":"4","author":"Shah","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2020.100151_bib70","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A\u00a0randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2020.100151_bib71","first-page":"G991","article-title":"IL-8 secretion and neutrophil activation by HT-29 colonic epithelial cells","volume":"267","author":"Kelly","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhepr.2020.100151_bib72","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41598-018-38125-x","article-title":"IL-10 produced by macrophages regulates epithelial integrity in the small intestine","volume":"9","author":"Morhardt","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2020.100151_bib73","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/0300985814559404","article-title":"Epithelial cell shedding and barrier function: a matter of life and death at the small intestinal villus tip","volume":"52","author":"Williams","year":"2015","journal-title":"Vet Pathol"},{"key":"10.1016\/j.jhepr.2020.100151_bib74","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/apt.12194","article-title":"Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies","volume":"37","author":"Adriaanse","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2020.100151_bib75","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1553-2712.2010.00792.x","article-title":"Intestinal-FABP and liver-FABP: novel markers for severe abdominal injury","volume":"17","author":"Relja","year":"2010","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jhepr.2020.100151_bib76","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/SLA.0b013e3181d778c4","article-title":"Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis","volume":"251","author":"Thuijls","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2020.100151_bib77","first-page":"1619","article-title":"D-lactate in human and ruminant metabolism","volume":"135","author":"Ewaschuk","year":"2005","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jhepr.2020.100151_bib78","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11239-011-0660-z","article-title":"Current status on plasma biomarkers for acute mesenteric ischemia","volume":"33","author":"Acosta","year":"2012","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jhepr.2020.100151_bib79","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1128\/AEM.00527-15","article-title":"Utilization of d-lactate as an energy source supports the growth of Gluconobacter oxydans","volume":"81","author":"Sheng","year":"2015","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jhepr.2020.100151_bib80","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/mpat.1996.0122","article-title":"Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia","volume":"22","author":"Bongaerts","year":"1997","journal-title":"Microb Pathog"},{"key":"10.1016\/j.jhepr.2020.100151_bib81","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","article-title":"Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study","volume":"42","author":"Kirpich","year":"2008","journal-title":"Alcohol"},{"key":"10.1016\/j.jhepr.2020.100151_bib82","doi-asserted-by":"crossref","first-page":"e0193202","DOI":"10.1371\/journal.pone.0193202","article-title":"Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines","volume":"13","author":"Bourgonje","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2020.100151_bib83","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/gutjnl-2020-321388","article-title":"Faecal calprotectin indicates intestinal inflammation in COVID-19","volume":"69","author":"Effenberger","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2020.100151_bib84","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/gutjnl-2017-315545","article-title":"Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels","volume":"68","author":"Magro","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2020.100151_bib85","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fimmu.2019.00293","article-title":"Causes and consequences of innate immune dysfunction in cirrhosis","volume":"10","author":"Irvine","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2020.100151_bib86","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/1756-0500-6-431","article-title":"Vectorial secretion of interleukin-8 mediates autocrine signalling in intestinal epithelial cells via apically located CXCR1","volume":"6","author":"Rossi","year":"2013","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jhepr.2020.100151_bib87","doi-asserted-by":"crossref","first-page":"7650260","DOI":"10.1155\/2016\/7650260","article-title":"Cellular barriers after extravasation: leukocyte interactions with polarized epithelia in the inflamed tissue","volume":"2016","author":"Reglero-Real","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jhepr.2020.100151_bib88","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/acer.13498","article-title":"Continued alcohol misuse in human cirrhosis is associated with an impaired gut-liver axis","volume":"41","author":"Bajaj","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhepr.2020.100151_bib89","doi-asserted-by":"crossref","first-page":"e54646","DOI":"10.1371\/journal.pone.0054646","article-title":"Chronic alcohol exposure renders epithelial cells vulnerable to bacterial infection","volume":"8","author":"Wood","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2020.100151_bib90","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/hep.27489","article-title":"Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice","volume":"61","author":"Chen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100151_bib91","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molmed.2016.04.003","article-title":"Antibiotic-induced changes in the intestinal microbiota and disease","volume":"22","author":"Becattini","year":"2016","journal-title":"Trends Mol Med"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920300859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920300859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:26:30Z","timestamp":1762899990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555920300859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":91,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2589555920300859"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100151","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100151"}}